BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 21997961)

  • 1. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
    Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
    Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles.
    Deb S; Campbell BK; Clewes JS; Pincott-Allen C; Raine-Fenning NJ
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):216-22. PubMed ID: 22744915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
    van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
    Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
    van Heusden AM; Coelingh Bennink HJ; Fauser BC
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review.
    D'Arpe S; Di Feliciantonio M; Candelieri M; Franceschetti S; Piccioni MG; Bastianelli C
    Reprod Biomed Online; 2016 Oct; 33(4):436-448. PubMed ID: 27527655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early follicle development during the luteal-follicular transition affects the predictability of serum follicle-stimulating hormone but not antimüllerian hormone levels on cycle day 3.
    Grynberg M; Genro V; Gallot V; El-Ali A; Frydman R; Fanchin R
    Fertil Steril; 2010 Oct; 94(5):1827-31. PubMed ID: 19878941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
    Somunkiran A; Yavuz T; Yucel O; Ozdemir I
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile women: its agreement with conventional two-dimensional ultrasound and serum levels of anti-Müllerian hormone.
    Peres Fagundes PA; Chapon R; Olsen PR; Schuster AK; Mattia MMC; Cunha-Filho JS
    Reprod Biol Endocrinol; 2017 Dec; 15(1):96. PubMed ID: 29246176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
    Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
    Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.
    Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R
    Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation.
    Jayaprakasan K; Deb S; Batcha M; Hopkisson J; Johnson I; Campbell B; Raine-Fenning N
    Fertil Steril; 2010 Oct; 94(5):1775-81. PubMed ID: 19931077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.
    Arbo E; Vetori DV; Jimenez MF; Freitas FM; Lemos N; Cunha-Filho JS
    Hum Reprod; 2007 Dec; 22(12):3192-6. PubMed ID: 17981819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition.
    Yang YS; Hur MH; Kim SY; Young K
    Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.